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ABSTRACT 
The renal handling of salt and protons and bicarbonate are intricately linked through 
shared transport mechanisms for sodium, chloride, protons, and bicarbonate. In the 
collecting duct, the regulated fine-tuning of salt and acid-base homeostasis is 
achieved by a series of transport proteins located in different cell types, intercalated 
and principal cells. Intercalated cells are considered to be of less importance for salt 
handling but recent evidence has suggested that the anion exchanger pendrin may 
participate in salt reabsorption and blood pressure regulation. Here, we examined the 
regulated expression of two functionally related but differentially expressed anion 
exchangers, AE1 and pendrin, by dietary electrolyte intake and aldosterone. Cortical 
expression of pendrin was regulated on mRNA and protein level. The combination of 
NaHCO3 and DOCA enhanced pendrin mRNA and protein levels, whereas DOCA or 
NaHCO3 alone had no effect. NaCl or KHCO3 increased pendrin mRNA, KCl 
decreased its mRNA abundance. On protein level, NH4Cl, NaCl, and KCl reduced 
pendrin expression, the other treatments were without effect. In contrast, AE1 mRNA 
or protein expression in kidney cortex was regulated by none of these treatments. In 
kidney medulla, NaHCO3/DOCA or NaHCO3 alone enhanced AE1 mRNA levels. AE1 
protein abundance was increased by NH4Cl, NaHCO3/DOCA, and NaCl. 
Immunolocalization showed that during NH4Cl treatment the relative number of AE1 
positive cells was increased and pendrin expressing cells reduced. Thus, pendrin and 
AE1 are differentially regulated with distinct mechanisms that separately affect mRNA 
and protein levels.  Pendrin is regulated by acidosis and chloride intake, whereas 
AE1 is enhanced by acidosis, NaCl, and the combination of DOCA and NaHCO3.  
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INTRODUCTION 
 
The rate of renal excretion or reabsorption, respectively, of sodium and 
chloride determines extracellular volume and blood pressure. Stimulation of NaCl 
reabsorptive processes causes an expansion of extracellular volume and increases 
blood pressure whereas renal loss of salt is associated with low blood pressure. The 
importance of renal salt handling for blood pressure regulation has been highlighted 
by rare Mendelian syndromes with mutations in more than 20 different transport 
proteins, ion channels or regulators of renal salt handling [1].  
Sodium and chloride may be transported by the same transport protein such 
as the Na+/K+/2Cl- -cotransporter NKCC2 in the thick ascending limb of the loop of 
Henle or the Na+/Cl- -cotransporter NCC in the distal convoluted tubule [2,3,4,5]. In 
contrast, these ions are reabsorbed by distinct transport pathways in the late distal 
convoluted tubule, in the connecting tubule, and in the collecting duct [6]. Sodium is 
reabsorbed by the epithelial sodium channel (ENaC), which is expressed in principal 
cells, targeted by potassium-sparing diuretics, and regulated by a variety of 
hormones including angiotensin II and aldosterone [6]. Chloride appears to take two 
different routes, either the paracellular pathway that may be controlled by claudins 
[7], or the transcellular route through non-type A intercalated cells. These cells 
express on their luminal pole the anion exchanger pendrin (SLC26A4) reabsorbing 
chloride in exchange for intracellular bicarbonate in an electroneutral manner 
[8,9,10,11,12,13]. The driving force for Cl- -reabsorption is provided by the gradient 
for bicarbonate, which depends on the activity of H+-ATPases localized either on the 
luminal and/or basolateral pole of the same cells and thereby energizing pendrin-
dependent transport processes [14,15,16]. The activity of pendrin is also indirectly 
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regulated by angiotensin II [14,17] and loss of pendrin reduces ENaC expression and 
activity linking sodium and chloride reabsorption [18,19,20,21]. Moreover, mice 
lacking pendrin are resistant to hypertension induced by high salt and 
mineralocorticoid treatment [22].  
A third type of cells exists along the collecting duct, type A intercalated cells, 
that are critical for renal acid excretion [15]. Type A intercalated cells are 
characterized by the expression of luminal H+-ATPases acidifying urine and by the 
basolateral presence of the chloride/bicarbonate exchanger AE1 (SLC4A1) [15,23]. 
The activity of type A intercalated cells is classically not linked to blood pressure 
regulation. However, patients with inherited forms of distal renal tubular acidosis, 
syndromes of dysfunction of intercalated cells, have a mild renal salt loosing 
phenotype suggesting a contribution of type A intercalated cells to overall renal salt 
handling [24].  
The response of pendrin to dietary chloride intake and distal urine chloride 
delivery has been studied in vivo in some detail [25,26,27,28]. Promoter studies in 
vitro demonstrated increased transcription of pendrin stimulated by aldosterone [29] 
consistent with higher mRNA expression after treatment with the aldosterone 
analogue desoxycorticosterone acetate (DOCA) [22]. Similarly, the activity of type A 
intercalated cells has been reported to be stimulated by aldosterone [30,31]. 
However, the impact of different electrolytes and their interactions with aldosterone 
has not been studied in vivo. This is of major importance to understand the regulation 
of these transport proteins which are critical for renal salt reabsorption and blood 
pressure regulation. Therefore we systematically compared the effect of various 
electrolytes and the additional influence of aldosterone on the expression of pendrin 
and AE1 in vivo in mouse kidney. Moreover, we examined the remodeling of the 
5 
 
collecting duct by these treatments showing that mRNA and protein expression levels 
were affected with distinct patterns and that the relative cell numbers along the 
collecting duct were also modulated.  
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MATERIALS AND METHODS 
 
Animal studies and metabolic cages 
 Male, C57Bl/6 mice (25-30g, Institute of Laboratory Animal Sciences, 
University of Zurich) were maintained on standard chow and had free access to 
drinking water. The mice were divided into 7 different treatment groups: 1) 0.28 M 
NH4Cl, 2) 0.28 M NaHCO3 and additional subcutaneous injections of 
deoxycorticosterone acetate (DOCA) at day 1 and 4 (2 mg/ mouse), 3) 0.28 M NaCl, 
4) subcutaneous injections of DOCA at day 1 and 4 (2 mg/ mouse), 5) 0.28 M 
NaHCO3, 6) 0.28 M KCl, and 7) 0.28 M KHCO3. Each group consisted of at least 10 
animals and was compared to the corresponding control group. All diets were given 
in drinking water in addition to 1% sucrose. Control mice were only treated with 1% 
sucrose. All animals were subjected to the diet for 7 days and placed in metabolic 
cages for the final 3 days. Daily chow and water intake, stool excretion, body weight, 
and urine excretion (collected under mineral oil) were monitored. At the end of the 
experiment, animals were perfused with PBS, and both kidneys were harvested, 
immediately dissected into cortex and medulla, frozen in liquid nitrogen, and stored at 
-80°C until further processing. Animal studies were according to Swiss Animal 
Welfare Laws and approved by the local Veterinary Authority (Kantonales 
Veterinaeramt Zurich). 
 
 Urine analysis 
 Urinary pH was measured using a pH microelectrode (691 pH-meter, 
Metrohm, Switzerland). Urinary ammonium was determined according to the 
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Berthelot protocol [32]. Urinary phosphate was determined by the Fiske and 
Subbarow colorimetric method. Briefly, standard solutions were prepared from 11.7 
mM phosphate stock solution (Randox Laboratories, United Kingdom). After protein 
precipitation with 20% trichloroacetic acid, urine and serum samples were pipetted 
into a 96-well plate. After addition of acid molybdate solution and Fiske and 
Subbarow reducer solution (Sigma, MO, USA) the absorbance of the samples was 
measured at 660 nm wavelength using a μQuant microplate reader (Biotek, 
Germany). Urinary electrolytes (Na+, K+, Ca2+, Mg2+, Cl-) were measured by ion 
chromatography (Metrohm ion chromatograph, Herisau, Switzerland) and urinary 
creatinine was determined by the Jaffe method [33,34].  
 
RNA extraction from kidney and reverse transcription 
 Snap-frozen kidneys were homogenized in RLT-Buffer (Qiagen, Basel, 
Switzerland) containing 2-mercaptoethanol (Sigma, Buchs, Switzerland) at a final 
concentration of 1%. Total RNA was extracted from 200 μl aliquots of each 
homogenized sample using the RNeasy Mini Kit (Qiagen, Basel, Switzerland) 
according to the manufacturer’s instructions. Quantity and quality of total eluted RNA 
were assessed by spectrometry using the ND-1000 spectrophotometer (NanoDrop 
Technologies, DE, USA). Each RNA sample was diluted to 100 ng/μl, and 3 μl was 
used as a template for reverse transcription using the TaqMan Reverse Transcription 
Kit (Applied Biosystems, Foster City, CA, USA) according to manufacturer’s protocol. 
Remaining RNA samples were stored at -80°C. 
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Semiquantitative real-time RT-PCR  
 Semiquantitative real-time RT-PCR (qRT-PCR) was performed on the ABI 
PRISM 7700 Sequence Detection System (Applied Biosystems, Foster City, CA, 
USA). Primers for all genes of interest were designed using Primer Express software 
from Applied Biosystems and primers and probes were used as described previously 
[35,36]. Probes were labeled with the reporter dye FAM at the 5’ end and the 
quencher dye TAMRA at the 3’ end (Microsynth, Balgach, Switzerland). The 
specificity of all primers was first tested in a standard PCR and always resulted in a 
single product of the expected size on 1% agarose gels (data not shown). Real-time 
PCR reactions were performed using the TaqMan Universal PCR Master Mix 
(Applied Biosystems, Foster City, CA, USA). Briefly, a 25 (20) µl PCR reaction 
volume was prepared using 3.5 (3) µl cDNA as template with sense and antisense 
primers (25 µM each), the labeled probed (5 µM), the Taqman Universal PCR Master 
Mix and RNase free water up to the final volume. Thermal cycles were set for 
denaturation at 95 ºC (10 min) followed by 40 cycles of denaturation at 95 ºC (15 s) 
and annealing/elongation at 60 ºC (1 min) with auto ramp time. All reactions were run 
in triplicates. To analyze the data, we set the threshold to 0.06 as this value had been 
determined to be in the linear range of the amplification curves for all mRNAs in all 
experimental runs. The expression of gene of interest was calculated in relation to 
hypoxanthine guanine phosphoribosyl transferase (HPRT). Relative expression ratios 
were calculated as R = 2[Ct(HPRT)-Ct(test gene)], where Ct represents the cycle number at 
the threshold 0.06.  
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Membrane preparation and western blot analysis 
 For total membrane preparation kidney cortex or medulla samples were 
homogenized in an ice-cold K-HEPES buffer (200 mM mannitol, 80 mM HEPES, 41 
mM KOH, pH 7.5) containing a protease inhibitor mix (Complete Mini, Roche 
Diagnostics, Germany) at a final concentration of 1 tablet in a volume of 10 ml 
solution. Samples were centrifuged at 2000 rpm for 20 min at 4°C. Subsequently, the 
supernatant was transferred to a new tube and centrifuged at 41000 rpm for 1 h at 
4°C. The resultant pellet was resuspended in K-HEPES buffer containing protease 
inhibitors. After measurement of the total protein concentration (Bio-Rad Dc Protein 
Assay; Bio-Rad, Hercules, CA, USA), 50 or 75 µg of crude membrane proteins were 
solubilized in Laemmli sample buffer, and SDS-PAGE was performed on 8-10% 
polyacrylamide gels. For immunoblotting, proteins were transferred 
electrophoretically to polyvinylidene difluoride membranes (Immobilon-P; Millipore, 
Bedford, MA, USA). After blocking with 5% milk powder in Tris-buffered saline/0.1% 
Tween-20 for 60 min, the blots were incubated with the respective primary antibodies 
(rabbit anti-pendrin 1:5000 [25], rabbit anti-AE1 1:10000 [33], diluted in 1%milk/TBS-
T) and mouse monoclonal anti-β-actin antibody (42 kDa; Sigma, St. Louis, MO, USA) 
1:5000 either for 2 h at room temperature or overnight at 4°C. After washing and 
subsequent blocking, the membranes were incubated for 1 h at room temperature 
with the secondary antibody. Following secondary antibodies were used where 
appropriate: donkey anti-rabbit IgG-conjugated with horseradish peroxidase 1:10000 
(GE Healthcare, United Kingdom), sheep anti-mouse IgG-conjugated with 
horseradish peroxidase 1:10000 (GE Healthcare, United Kingdom), and goat anti-
rabbit or anti-mouse IgG-conjugated with alkaline phosphatase 1:5000 (Promega, WI, 
USA). Antibody binding was detected with the ImmobilonTM Western 
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chemiluminescence kit (Millipore; Billerica, MA, USA) using the DIANA III-
chemiluminescence detection system (Raytest; Straubenhardt, Germany). All images 
were analyzed using appropriate software (Advanced Image Data Analyzer, Raytest, 
Straubenhardt, Germany) to calculate the protein of interest/β-actin ratio. 
 
Immunohistochemistry 
 Mice were anesthetized as described above and subsequently perfused 
through the left ventricle with PBS followed by a paraformaldehyde-lysine-periodate 
fixative [37]. Kidneys were removed and fixed overnight at 4°C by immersion in 
paraformaldehyde-lysine-periodate. Kidneys were washed three times with PBS, and 
after cryoprotection with PBS/30% sucrose solution, thin coronal slices were cut, 
mounted on cryomolds, and frozen in liquid propane cooled with liquid nitrogen. 
Immunostaining was carried out as described previously [38]. Briefly, 5 µm thin 
sections were incubated with 1% SDS for 5 min, washed three times with PBS, and 
incubated with PBS containing 1% BSA for 15 min before application of the primary 
antibody. The primary antibodies (rabbit anti-AE1 1:10000 [33], guinea pig anti-
pendrin 1:2000 [25], mouse anti-calbindin 1:40000 (SWANT, Bellinzona, Switzerland) 
and goat anti-AQP2 1:400 (Chemicon (Millipore), Zug, Switzerland) were diluted in 
PBS/0.02% Na-azide and applied either for 75 min at room temperature or overnight 
at 4°C. Sections were then washed twice for 5 min with high-NaCl-PBS (PBS+ 18 g 
NaCl/l), once with PBS, and incubated with the secondary antibodies (donkey anti-
rabbit Alexa 594 1:1000, donkey anti-guinea pig Cy2 1:400, donkey anti-mouse Cy5 
1:500, donkey anti-goat Cy5 1:500 (Invitrogen, Basel, Switzerland) and DAPI 1:500 
(Sigma)) at the given dilutions for 1 h at room temperature. Sections were again 
washed twice with high-NaCl-PBS and once with PBS before being mounted with 
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Glycergel (DakoCytomation, Glostrup, Denmark). Sections were viewed using a 
Leica DFC490 charged-coupled device camera attached to a Leica DM 6000 
fluorescence microscope (Leica, Wetzlar, Germany) using equivalent camera 
parameters for kidneys sections stained with the same primary antibody. Pictures 
were processed using Imaris. Cell counting for the different subtypes of intercalated 
cells was performed as described previously [39]. 
 
Statistical Analysis 
Results are expressed as means ± SEM. All data were tested for significance using 
ANOVA and unpaired Student’s t-test where appropriate. Results with P < 0.05 were 
considered as significant. 
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RESULTS 
 
 The anion exchangers AE1 and pendrin have been shown to be regulated 
during acidosis and alkalosis [25,40,41,42,43]. In a first series of experiments mice 
received NH4Cl to induce metabolic acidosis, a combination of NaHCO3 and the 
aldosterone analogue deoxycorticosterone acetate (DOCA) to induce alkalosis, and 
NaCl to test for effects of sodium and chloride. Urine analysis confirmed the expected 
effects such as lower urine pH and increased ammonium excretion in NH4Cl-loaded 
mice or increased sodium excretion in mice treated with NaCl or NaHCO3 (table 1). 
Semiquantitative RT-PCR did not detect any difference in AE1 mRNA levels in kidney 
cortex (Figure 1A) but showed significantly elevated AE1 mRNA in kidney medulla in 
mice receiving NaHCO3 and DOCA (Figure 2A). Similarly, AE1 protein abundance in 
kidney cortex was not affected by treatments (Figure 1B,C), whereas NH4Cl and 
NaHCO3 in combination with DOCA significantly stimulated AE1 protein expression in 
kidney medulla (Figure 2B,C). Treatment with NaCl tended to increase AE1 mRNA 
and significantly enhanced protein in medulla (Figure 2C). 
 In the same mice, treatment with NaHCO3/DOCA or NaCl alone enhanced 
pendrin mRNA significantly; the combination of NaHCO3 and DOCA being more 
effective than NaCl (Figure 3A). On the protein level, NH4Cl significantly reduced 
pendrin abundance, whereas NaHCO3/DOCA increased pendrin expression (Figure 
3B,C). NaCl reduced pendrin expression, which reached almost statistical 
significance (p = 0.058). Pendrin expression was examined only in cortical 
preparations since pendrin is mostly expressed in the cortical segments of the 
collecting system (e.g. the late distal convoluted tubule, CNT and CCD). 
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 In a next series of experiments, we examined if the effects of NaHCO3/DOCA 
were induced by either NaHCO3 or DOCA alone, or by combined treatment. Mice 
received therefore either NaHCO3 or DOCA alone. The efficacy of treatments was 
confirmed by urine analysis (table 1). NaHCO3 or DOCA alone had no effect on AE1 
mRNA or protein expression in kidney cortex (Figure 4), whereas in medulla NaHCO3 
increased AE1 mRNA but not protein abundance (Figure 5). DOCA was without 
effect on mRNA and protein expression in cortex and medulla (Figure 5). Moreover, 
pendrin mRNA and protein abundance were unaffected by either of the treatments 
(Figure 6).  
 In a third series of experiments, we tested whether chloride or bicarbonate had 
different effects when combined with potassium instead of sodium as counter cation. 
Mice received either KCl or KHCO3 for 7 days and subsequently urine was analyzed 
to confirm effectiveness of treatment (table 1). Both diets were without significant 
effect on AE1 mRNA and protein abundance in kidney cortex and medulla (Figures 7 
and 8). In contrast, KCl reduced pendrin mRNA and protein significantly (Figure 9). 
KHCO3 treatment enhanced pendrin mRNA abundance approximately two-fold but 
pendrin protein expression remained unchanged (Figure 9). 
In a last series of experiments we examined the effects of NH4Cl, KCl, and 
NaHCO3 on the relative abundance and distribution of AE1 and pendrin expressing 
intercalated cell subtypes in kidney cortex and medulla. Detailed counting of cells in 
the different segments of the collecting system revealed significant changes only for 
animals receiving NH4Cl (table 2).  
In these animals, a significant increase of AE1 expressing cells in the 
connecting tubule (CNT) and outer medullary collecting duct (OMCD) was noted that 
was paralleled by a decrease of pendrin positive cells in the CNT and aquaporin 2 
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(AQP2) positive cells in the OMCD, respectively. All other small changes did not 
reach statistical significance (Figures 10 and 11, table 2). 
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DISCUSSION 
 Intercalated cells have been traditionally viewed as being important for the 
control of systemic acid-base homeostasis by excreting acid or base equivalents [15]. 
However, in more recent years several links to the renal control of salt and electrolyte 
handling have emerged. Secretion of potassium by flow-activated maxiK channels 
expressed in intercalated cells has been observed [44,45]. The identification of 
pendrin as major apical anion transporter in  non-type A intercalated cells has linked 
this cell type to the reabsorption of chloride and its impact on blood pressure 
regulation [8,22,28,46]. More recent work by Eladari and colleagues identified a Na+-
driven chloride/bicarbonate transporter, Slc4a8, that may in conjunction with pendrin 
mediate electroneutral NaCl reabsorption. Interestingly, the activity of Slc4a8 is also 
thiazide sensitive [18]. 
Here we demonstrate that expression of AE1 and pendrin is sensitive to 
dietary electrolyte intake and the aldosterone analogue DOCA. Several observations 
are important. First, regulation on mRNA and protein level do not always go in 
parallel, sometimes even in opposite directions calling for caution in drawing 
conclusions about protein expression from mRNA data. Of note, we did not 
determine transport activities in the present study, thus, our data on protein and cell 
abundances do not necessarily translate into changes in activity. However, the data 
on blood and urine composition indicate parallel changes suggesting that protein 
abundance and function may be closely linked. Second, AE1 mRNA and protein 
expression in cortex was unchanged in all groups whereas protein expression in 
kidney medulla was strongly regulated by NH4Cl, NaHCO3/DOCA, and NaCl. Third, 
regulation of AE1 in the medulla was only observed if NaHCO3 was combined with 
DOCA, but not in the groups receiving DOCA, NaHCO3 or KHCO3 alone. These data 
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therefore suggest, that alkali treatment, sodium, potassium or DOCA alone do not 
affect AE1 protein expression. DOCA, or its natural analogue aldosterone, may 
therefore have a permissive effect on AE1 expression when combined with alkalosis. 
This effect may be of clinical relevance in patients with stimulated aldosterone levels 
and alkalosis as seen in volume contracted patients and would consequently 
contribute to maintenance of alkalosis or even enhance it. The increase in AE1 
mRNA in medulla in NaHCO3 treated animals did not translate into more protein. 
NH4Cl increased AE1 protein but not mRNA abundance in medulla. Consistently, we 
did not detect significant AE1 mRNA changes in a genome-wide transcriptome 
analysis of mouse kidney during acidosis in earlier experiments [36]. Though, in rat 
kidney, AE1 is regulated by NH4Cl both on mRNA and protein level [43]. The reason 
for this species difference is presently unknown.  
Our study further showed that AE1 is not regulated by dietary chloride intake, 
since KCl failed to change AE1 abundance. On the other hand, NaCl tended to 
increase AE1 mRNA and stimulated protein expression in kidney medulla. Since 
NaHCO3 alone had no effect on AE1 mRNA or protein expression, we reason that 
sodium delivery alone does not regulate AE1. NaCl availability has been shown to 
enhance the kidneys ability to excrete acid [47]. Increased expression of AE1 under 
these conditions could contribute to removal of acid and generation of new 
bicarbonate.  
Pendrin regulation by aldosterone and various electrolytes has been studied in 
some detail [10,22,25,26,27,28,40,41,46]. Our results here confirm regulation of 
pendrin by chloride availability. Dietary supplementation with NH4Cl, NaCl or KCl 
increased urinary chloride excretion and reduced pendrin protein abundance.  
Interestingly, these treatments had different effects on pendrin mRNA expression. 
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KCl reduced mRNA levels, whereas NaCl increased it, and NH4Cl had no effect. 
Thus, chloride may not directly affect pendrin mRNA but additional factors must be 
operative that regulate pendrin transcription or mRNA stability.  
Mice were treated with bicarbonate in combination with either sodium or 
potassium as counter cations and in the absence or presence of DOCA, respectively. 
Bicarbonate alone did not regulate pendrin mRNA or protein over a period of 7 days 
since NaHCO3 alone did affect neither mRNA nor protein, whereas KHCO3 or 
NaHCO3 in combination with DOCA increased mRNA abundance. Only the 
combination of NaHCO3/DOCA increased also pendrin protein expression. DOCA 
alone was without effect on mRNA and protein. Thus, the combination of aldosterone 
and bicarbonate is a potent stimulus to enhance pendrin expression. In the case of 
KHCO3, the potassium load may increase serum aldosterone levels but to a lesser 
extent than in animals with DOCA administration. Our results are not in agreement 
with two previous reports. Verlander et al. reported that DOCP alone enhanced 
pendrin expression but mice had received additional NaCl supplements and only one 
application of DOCP seven days before organ collection [22]. We speculate that the 
additional NaCl load and the different application regimen may alter the response to 
the aldosterone analogue. Alternatively, the effect of DOCA or its analogues may be 
time-dependent and transient and only detectable after short treatments but not after 
7 days [48]. A second study addressed regulation of human pendrin transcription by 
aldosterone using HEK293 cells as cellular model. These cells are derived from 
human embryonic kidney and are not representative for collecting duct intercalated 
cells. In these cells, aldosterone suppressed pendrin transcription [29], while our 
results suggest that DOCA alone has no effect on pendrin mRNA abundance and 
that a second stimulus, i.e. bicarbonate, is needed to enhance pendrin mRNA. Thus, 
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transcriptional regulation of pendrin differs between cell models and in vivo [49], 
which may be the result of the interaction of several factors affecting the collecting 
duct, and not all transcriptional changes translate into altered protein abundance 
demonstrating an additional level of control. 
Remodeling of the collecting duct occurs in response to changes in electrolyte 
and/or acid-base status [25,38,40,50,51,52,53,54,55,56,57,58,59]. Induction of 
acidosis with NH4Cl has been shown to increase the relative number of type A 
intercalated cells in various rat and mouse models. AE1 protein expression increased 
during NH4Cl only in the medulla but not in cortex. In contrast, we found a higher 
relative number of AE1 expressing cells in both cortex and medulla during NH4Cl-
loading suggesting that in the cortex the abundance of AE1 per cell may be 
stimulated. Pendrin abundance in the cortex was reduced during NH4Cl loading and 
the relative number of pendrin positive cells decreased in parallel. However in KCl-
loaded animals, pendrin protein abundance decreased without a significant chance in 
the relative number of pendrin expressing cells consistent with a possible reduction of 
pendrin expression per cell. In both cases, the cellular mechanisms responsible for 
sensing changes in acid-base status or chloride concentrations are unknown. Also 
the mechanisms triggering the reduction in protein expression or cell number have 
not been identified to date. Several mechanisms have been suggested to be involved 
in the remodeling of the collecting duct in response to NH4Cl-induced acidosis 
including proliferation of type A intercalated cells and hensin-mediated 
interconversion of type A and non-A intercalated cells [56,59,60].  
 
In summary, the abundance of the two major anion exchangers AE1 and 
pendrin expressed in the different subtypes of intercalated cells is heavily regulated 
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by electrolyte intake, acid-base status, and the aldosterone analogue. In some 
instances the presence of two combined stimuli is required for regulation. Apparently, 
regulation involves changes in protein expression per cell as well as changes in the 
relative abundance of the two major intercalated cell subtypes. The adaptive 
regulation of the type A intercalated cell anion exchanger AE1 mainly follows 
changes in acid-base status whereas regulation of pendrin expression paralleled 
mostly chloride intake and acid-base status. Our data demonstrate differential 
regulation of these transporters and the two intercalated subtypes. The altered 
expression may support the renal response to changes in acid-base status and 
electrolyte intake but may also contribute in some instances to the maintenance of 
electrolyte and acid-base disturbances. 
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Table 1  
Summary of urine data from mice receiving different treatments 
 
 
 
 
 
 
 pH Volume/BW 
(g/g)  
PO4/creatinine 
(mM/mg/dl) 
NH4+/creatinine 
(mM/mg/dl) 
 
Na+/creatinine 
(mM/mg/dl) 
 
K+/creatinine 
(mM/mg/dl) 
 
Cl-/creatinine 
(mM/mg/dl) 
 
Control 1 6.19 ± 0.08 0.04 ± 0.01 1.00 ± 0.15 0.77 ± 0.19 1.97 ± 0.21 4.66 ± 0.28 4.56 ± 0.51 
NH4Cl 5.48 ± 0.02*** 0.04 ± 0.01 0.61± 0.17 6.54 ± 0.81** 2.57 ± 0.33 5.54 ± 0.51 11.68 ± 1.61** 
NaHCO3+DOCA 8.48 ± 0.15*** 0.10 ± 0.03 0.62 ± 0.21 0.08 ± 0.03*** 15.28 ± 2.01*** 3.83 ± 0.52 3.84 ± 0.36 
NaCl 6.30 ± 0.14 0.09 ± 0.02 0.79 ± 0.11 0.25 ± 0.02** 11.34 ± 0.89*** 3.93 ± 0.48 17.08 ± 2.18*** 
Control 2 6.28 ± 0.08 0.04 ± 0.01 0.93 ± 0.14 0.42 ± 0.02 2.23 ± 0.16 6.30 ± 0.44 4.44 ± 0.39 
DOCA 6.52 ± 0.02* 0.05 ± 0.01 1.10 ± 0.14 0.77 ± 0.06*** 2.88 ± 0.22* 7.72 ± 0.31* 5.80 ± 0.17** 
Control 3 6.34 ± 0.07 0.09 ± 0.01 1.41 ± 0.13 0.42 ± 0.03 2.71 ± 0.34 9.34 ± 1.11 5.17 ± 0.65 
NaHCO3 8.29 ± 0.18*** 0.05 ± 0.01 0.93 ± 0.10* 0.06 ± 0.01*** 13.12 ± 0.47*** 6.47 ± 0.40 3.87 ± 0.30 
Control 4 6.00 ± 0.13 0.05 ± 0.00  0.94 ± 0.06 0.79 ± 0.20 1.34 ± 0.05 5.19 ± 0.33 3.59 ± 0.27 
KCl 5.75 ± 0.17 0.12 ± 0.03* 1.36 ± 0.12* 0.66 ± 0.16 3.15 ± 0.28*** 29.70 ± 4.07*** 24.96 ± 4.97** 
KHCO3 8.11 ± 0.09*** 0.10 ± 0.01** 1.07 ± 0.16 0.23 ± 0.13* 1.97 ± 0.34 20.21 ± 2.48*** 4.56 ± 0.60 
Table 2. Relative abundance of the various cells types along the collecting system in 
kidneys from control mice and mice treated with KCl, NH4Cl, or NaHCO3  
 
 AE1 pos, Pendrin neg, 
AQP2 neg, % 
Pendrin pos, AE1 neg, 
AQP2 neg, % 
AQP2 pos, AE1 neg, 
Pendrin neg , % 
CNT    
Control 13.1 ± 0.7 (441)  30.5 ± 0.8 (1014) 54.8 ± 0.8 (1720) 
KCl 13.6 ± 0.6 (537) 28.6 ± 0.6 (1138) 57.4 ± 0.7 (2369) 
NH4Cl       17.1 ± 0.4 (1264) ***     25.0 ± 0.5 (1821) *** 57.6 ± 0.5 (4166)  
NaHCO3 15.1 ± 0.6 (648) 
 
30.2 ± 0.6 (1383) 54.6 ± 0.7 (2504)  
CCD    
Control 16.6 ± 1.0 (136) 19.7 ± 1.0 (162) 63.7 ± 1.3 (521) 
KCl 13.5 ± 1.4 (91)  20.2 ± 1.6 (119) 65.6 ± 2.2 (440) 
NH4Cl 16.5 ± 1.4 (167)  19.5 ± 1.1 (204)  63.9 ± 1.3 (654)  
NaHCO3 14.8 ± 1.5 (148) 21.7 ±  1.4 (233) 63.3 ± 1.7 (668) 
 
OMCD    
Control 26.9 ± 3.1 (112) 6.6 ± 2.1 (13) 65.6 ± 2.4 (256) 
KCl 29.2 ± 2.4 (153) 2.6 ± 1.7 (7) 67.3 ± 2.2 (364) 
NH4Cl   33.8 ± 1.6 (335) * 3.0 ± 1.4  (9)   63.2 ± 1.5 (611) * 
NaHCO3 31.4 ± 1.7 (244) 2.2 ± 1.5 (7) 66.3 ± 1.4 (484) 
 
IMCDi    
Control 22.2 ± 1.4 (263) 0 ± 0 (0) 77.5 ± 1.5 (1012) 
KCl 19.6 ± 3.0 (118) 0 ±  0 (0) 80.4 ± 3.0 (626) 
NH4Cl 21.8 ± 2.8 (294) 0 ± 0 (0) 78.2 ± 2.8 (1119) 
NaHCO3 21.4 ± 2.6 (350) 0 ± 0 (0) 78.6 ± 2.6 (1515) 
 
 Values are means ± SE, with the number of cells counted in parentheses. Shown is 
a summary of cell counts in the different segments of the collecting system, 5 
animals in each group were analyzed, and cells were counted. CNT, connecting 
tubule; CCD, cortical collecting duct; OMCD, outer medullary collecting duct; IMCDi, 
initial segment of the inner medullary collecting duct. Significant difference between 
control and treatment groups: * p < 0.05, ** p < 0.01, *** p < 0.001.  
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FIGURE LEGENDS 
 
Table 1. Urine parameters of all treatment groups 
All animals were treated for 7 days and placed into metabolic cages for the final 3 
days. Urine analysis was performed from samples collected under mineral oil over 
the last 24 hrs. Values are means ± SE; n = 5-7/group. Shown is a summary of 
urinary data from all different treatment groups and the corresponding controls. BW, 
body weight, crea creatinine. * p< 0.05, ** p< 0.01, *** p< 0.001. 
 
Table 2. Relative abundance of cell types along the collecting system 
Kidney sections from animals receiving sucrose (control), NH4Cl, KCl, or NaHCO3 for 
7 days were stained for AE1, pendrin, AQP2/calbindin D28k, and DAPI and cells 
counted for the various markers and distinct segments. The total number of cells 
counted is given in brackets, for each condition n = 5 animals were counted. * p< 
0.05, ** p< 0.01, *** p< 0.001. 
 
Figure 1. AE1 expression is not regulated in kidney cortex.  
The mRNA and protein abundance of the type A intercalated cell specific Cl-/HCO3- 
exchanger AE1 was measured by real-time RT-PCR (A) and immunoblotting (B) in 
kidney cortex. (C) Bar graphs summarizing data from immunoblotting. All data were 
normalized against β-actin obtained on the same immunoblotting membrane after 
stripping. Data are given as normalized mean ± SE; n = 5-7 animals/group.  
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Figure 2. Regulated expression of AE1 in kidney medulla 
mRNA and protein abundance of the type A intercalated cell specific Cl-/HCO3- 
exchanger AE1 was measured by real-time RT-PCR (A) and immunoblotting (B) in 
kidney medulla. (C) Bar graphs summarizing data from immunoblotting. All data were 
normalized against β-actin obtained on the same immunoblotting membrane after 
stripping. Data are given as normalized mean ± SE; n = 5-7 animals/group.  *p  ≤ 
0.05, **p ≤  0.01. 
 
Figure 3. Pendrin expression in kidney cortex regulated by various treatments  
The mRNA and protein abundance of the type B intercalated cell specific Cl-/HCO3- 
exchanger pendrin was measured by real-time RT-PCR (A) and immunoblotting (B) 
in kidney cortex. (C) Bar graphs summarizing data from immunoblotting. All data 
were normalized against β-actin obtained on the same immunoblotting membrane 
after stripping. Data are given as normalized mean ± SE; n = 5-7 animals/group.  *p  
≤ 0.05, **p ≤  0.01. 
 
Figure 4. DOCA or NaHCO3 alone do not alter AE1 expression in kidney cortex 
The mRNA and protein abundance of AE1 in kidney cortex from mice treated with 
NaHCO3 or DOCA alone was measured by real-time RT-PCR (A, B) and 
immunoblotting (C) in the kidney cortex. (D) Bar graphs summarizing data from 
immunoblotting. All data were normalized against β-actin obtained on the same 
immunoblotting membrane after stripping. Data are given as normalized mean ± SE; 
n = 5-7 animals/group. 
24 
 
 
Figure 5. NaHCO3 increases mRNA expression of AE1 in kidney medulla 
The mRNA and protein abundance of AE1 in kidney medulla from mice treated with 
NaHCO3 or DOCA alone was measured by real-time RT-PCR (A,B) and 
immunoblotting (C) in kidney medulla. (D) Bar graphs summarizing data from 
immunoblotting. All data were normalized against β-actin. Data are given as 
normalized mean ± SE; n = 5-7 animals/group.  *p  ≤ 0.05,  
 
Figure 6. Pendrin expression is not regulated by DOCA or NaHCO3 alone 
Pendrin mRNA and protein abundance in kidney cortex from mice treated with 
NaHCO3 or DOCA alone for 7 days was measured by real-time RT-PCR (A,B) and 
immunoblotting (C) . All membranes were stripped and reprobed for β-actin. (D) Bar 
graphs summarizing data from immunoblotting. All data were normalized against β-
actin. Data are given as normalized mean ± SE; n = 5-7 animals/group. 
 
Figure 7.  AE1 in cortex is not affected by dietary KCl and KHCO3  
AE1 mRNA and protein abundance in kidney cortex from mice treated with KCl or 
KHCO3 for 7 days was measured by real-time RT-PCR(A) and immunoblotting (B). 
All membranes were stripped and reprobed for β-actin. (C) Bar graphs summarizing 
data from immunoblotting. All data were normalized against β-actin. Data are given 
as normalized mean ± SE; n = 5-7 animals/group.   
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Figure 8.  Medullay AE1 is not regulated by KCl and KHCO3  
AE1 mRNA and protein abundance in kidney medulla from mice treated with KCl or 
KHCO3 for 7 days were measured by real-time RT-PCR (A) and immunoblotting(B). 
All membranes were stripped and reprobed for β-actin. (C) Bar graphs summarizing 
data from immunoblotting. All data were normalized against β-actin. Data are given 
as normalized mean ± SE; n = 5-7 animals/group.   
 
Figure 9.  KCl and KHCO3 regulate pendrin expression  
Pendrin mRNA and protein abundance in kidney cortex from mice treated with KCl or 
KHCO3 for 7 days were examined by real-time RT-PCR (A) and immunoblotting (B). 
All membranes were stripped and reprobed for β-actin. (C)  Bar graphs summarizing 
data from immunoblotting. All data were normalized against β-actin. Data are given 
as normalized mean ± SE; n = 5-7 animals/group.  *p  ≤ 0.05, **p ≤  0.01, ***p ≤  
0.001. 
 
Figure 10. Remodeling of the collecting duct 
Kidneys from mice left untreated (sucrose, control) or receiving KCl, NaHCO3 or 
NH4Cl for 7 days were sectioned and stained for specific cell markers (AE1 for type A 
intercalated cells, pendrin for non-type A intercalated cells, and calbindin D28k and 
AQP2 for principal cells). The relative number of cells expressing these markers was 
counted for the different segments of the collecting system. CNT connecting tubule, 
CCD cortical collecting duct, OMCD outer medullary collecting duct, iIMCD initial 
inner medullary collecting duct, *p  ≤ 0.05, ***p ≤  0.001. 
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Figure 11. Immunolocalization of intercalated cell subtypes in mouse kidney 
under different dietary treatments 
Mice were left untreated (sucrose, control) or received NH4Cl, NaHCO3 or KCl in their 
drinking water for 7 days. Immunohistochemistry was performed to identify type A 
intercalated cells with AE1 (red), non-type A intercalated cells with pendrin (green), 
principal cells with calbindin D28k/AQP2 (yellow), and nuclei (DAPI, blue). 
Representative pictures are shown from CNT (A) and CCD (B). Original 
magnification 400x.  
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Figure 6 Mohebbi et al., Regulation of AE1 and pendrin
0 75
1.00
1.25
N
A 
ab
un
da
nc
e
2
N
A 
ab
un
da
nc
e
A B
control DOCA
0.00
0.25
0.50
.
no
rm
al
iz
ed
 m
R
N
control NaHCO3
0
1
no
rm
al
iz
ed
 m
R
N
C D
control DOCA
Pendrin 2
3
/A
ct
in
Pendrin
control NaHCO3
β-Actin
control DOCA
0
1
P
en
dr
in
/
8
10
ct
in
β-Actin
control NaHCO3
0
2
4
6
P
en
dr
in
/A
c
AE1 expression in cortex
Figure 7 Mohebbi et al., Regulation of AE1 and pendrin
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Figure 8 Mohebbi et al., Regulation of AE1 and pendrin
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Figure 9 Mohebbi et al., Regulation of AE1 and pendrin
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Figure 10   Mohebbi et al, Regulation of AE1 and pendrin 
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